2Seventy Bio Inc expected to post a loss of 24 cents a share - Earnings Preview

2Seventy Bio

08/11/2024 16:30

* 2Seventy Bio Inc  TSVT.OQ   TSVT.O  is expected to show a
rise
in quarterly revenue when it reports  results on November 12 for
the period ending September 30 2024
    * The Cambridge Massachusetts-based  company is expected to
report
a 24.9% increase in revenue to $15.036 million from $12.03
million a year ago, according to the mean estimate from 5
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for 2Seventy Bio Inc is for
a loss
of 24 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for 2Seventy
Bio Inc
is $8.00​, above​ its last closing price of $5.01. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -0.76       -0.65      0.45      Beat    169.5
 Mar. 31 2024  -0.79       -0.81      -1.01     Missed  -24.4
 Dec. 31 2023  -1.05       -0.99      -1.11     Missed  -12.1​
 Sep. 30 2023  -1.20       -1.03      -1.00     Beat    2.8
 ​​Jan.        -1.09       -1.06      -0.83     Beat    22.1
 1 0001                                                 
 Mar. 31 2023  -1.20       -1.19      -1.08     Beat    9.5​
 Dec. 31 2022  -1.59       -1.61      -0.60     Beat    62.6
 Sep. 30 2022  -1.86       -1.80      -1.76     Beat    2.5
 This summary was machine generated November 8 at 16:30 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)